access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Surgical Oncology Research

Surgery

The surgical oncology research section is composed of four highly interactive research laboratories focused on developing novel cancer therapies with a bench to bedside translational approach. Areas of priority include:  cancer immunotherapy, tumor angiogenesis, and the development of human tumor models to predict drug efficacy. All four laboratories are highly integrated between themselves and with other research groups within the Hollings Cancer Center.

Surgical Oncology Laboratories:

E. Ramsay Camp, M.D. 

The physician - scientists and researchers in Dr. Camp's Lab at MUSC are conducting research aimed at identifying new treatments for colorectal cancer.

Publication Search on PubMed 
Search on "E Ramsay Camp"

Nancy DeMore, M.D. FACS

Dr. DeMore studies angiogenesis as it relates to tumor progression and develops novel angiogenesis inhibitors.

Publication Search on PubMed 
Search on "Klauber-Demore"
Search on "Klauber"

Shikhar Mehrotra, Ph.D.

Dr. Mehrotra studies mechanisms for T cell immunity, T cell tolerance and how these can be modulated to control tumor and autoimmunity. 

Mark P. Rubinstein, Ph.D.

Mark P. Rubinstein, Ph.D. and his team are focused on developing novel immune-based therapies for the treatment of cancer. 

Publication Search on PubMed 
Search on "rubinstein mp"